The ATRIBIXA brand, founded in 2013 (Sweden), from 28 sister brands and 4958 competing brands. The ATRIBIXA brand is owned by Swedish Orphan Bio, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is SE0000872095. ATRIBIXA is part of the Drug Manufacturers activity sector.
Share price and profitability of the share Swedish Orphan Bio (ATRIBIXA)
Buy Swedish Orphan Bio share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Swedish Orphan Bio
(ATRIBIXA)
over 5 years*
EUR 17.03
Stock market history Swedish Orphan Bio (ATRIBIXA)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
